Literature DB >> 11017821

The role of physical proximity in nosocomial diarrhea.

V T Chang1, K Nelson.   

Abstract

To examine physical proximity as a risk factor for the nosocomial acquisition of Clostridium difficile-associated diarrhea (CDAD) and of antibiotic-associated diarrhea (AAD), we assessed a retrospective cohort of 2859 patients admitted to a community hospital from 1 March 1987 through 31 August 1987. Of these patients, 68 had nosocomial CDAD and 54 had nosocomial AAD. In multivariate analysis, physical proximity to a patient with CDAD (relative risk [RR], 1.86; 95% confidence interval [CI], 1.06-3.28), exposure to clindamycin (RR, 4.22; 95% CI, 2.11-8.45), and the number of antibiotics taken (RR, 1.49; 95% CI, 1.23-1.81) were significant. For patients with nosocomial AAD, exposure to a roommate with AAD (RR, 3.94; 95% CI, 1. 27-12.24), a stay in an intensive care unit or cardiac care unit (RR, 1.93; 95% CI, 1.05-3.53), and the number of antibiotics taken (RR, 2.01; 95% CI, 1.67-2.40) were significant risk factors. Physical proximity may be an independent risk factor for acquisition of nosocomial CDAD and AAD.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11017821     DOI: 10.1086/314030

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  22 in total

1.  Risk factors for acquisition of Clostridium difficile-associated diarrhea among outpatients at a cancer hospital.

Authors:  Tara N Palmore; SeJean Sohn; Sharp F Malak; Janet Eagan; Kent A Sepkowitz
Journal:  Infect Control Hosp Epidemiol       Date:  2005-08       Impact factor: 3.254

2.  Diarrhoea developing in hospital patients.

Authors:  R M McLoughlin; H J O'Connor
Journal:  Ir J Med Sci       Date:  2005 Jan-Mar       Impact factor: 1.568

3.  2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings.

Authors:  Jane D Siegel; Emily Rhinehart; Marguerite Jackson; Linda Chiarello
Journal:  Am J Infect Control       Date:  2007-12       Impact factor: 2.918

4.  Association between Clostridium difficile infection and antimicrobial usage in a large group of English hospitals.

Authors:  Joao B Pereira; Tracey M Farragher; Mary P Tully; Jonathan Jonathan Cooke
Journal:  Br J Clin Pharmacol       Date:  2014-05       Impact factor: 4.335

Review 5.  Clostridioides difficile (formerly Clostridium difficile) infection in the critically ill: an expert statement.

Authors:  Massimo Antonelli; Ignacio Martin-Loeches; George Dimopoulos; Antonio Gasbarrini; Maria Sole Vallecoccia
Journal:  Intensive Care Med       Date:  2020-01-14       Impact factor: 17.440

6.  Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA).

Authors:  L Clifford McDonald; Dale N Gerding; Stuart Johnson; Johan S Bakken; Karen C Carroll; Susan E Coffin; Erik R Dubberke; Kevin W Garey; Carolyn V Gould; Ciaran Kelly; Vivian Loo; Julia Shaklee Sammons; Thomas J Sandora; Mark H Wilcox
Journal:  Clin Infect Dis       Date:  2018-03-19       Impact factor: 9.079

7.  Infant neurobehavioral development.

Authors:  Barry M Lester; Robin J Miller; Katheleen Hawes; Amy Salisbury; Rosemarie Bigsby; Mary C Sullivan; James F Padbury
Journal:  Semin Perinatol       Date:  2011-02       Impact factor: 3.300

8.  Environmental transmission of Clostridium difficile: association between hospital room size and C. difficile Infection.

Authors:  Justine Jou; John Ebrahim; Frances S Shofer; Keith W Hamilton; John Stern; Jennifer H Han
Journal:  Infect Control Hosp Epidemiol       Date:  2015-02-05       Impact factor: 3.254

Review 9.  Clostridium difficile infection: epidemiology, diagnosis and understanding transmission.

Authors:  Jessica S H Martin; Tanya M Monaghan; Mark H Wilcox
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-03-09       Impact factor: 46.802

10.  [Antibiotic induced diarrhea and pseudomembranous colitis].

Authors:  C Greb; T Kalem; T Kälble
Journal:  Urologe A       Date:  2002-12-19       Impact factor: 0.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.